EGFR Positive Lung Cancer UK shared a post on X:
“We need MORE EGFR+ lung cancer pts on TKIs/targeted trmts to share experiences with side effects.
We’ve extended our survey deadline to 31 Aug. for the fantastic response so far.
Your input will help us deliver impactful insights at ESMO and beyond.”
Source: EGFR Positive Lung Cancer UK/X